Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

2.

Behavioral effects of cannabinoid agents in animals.

Chaperon F, Thiébot MH.

Crit Rev Neurobiol. 1999;13(3):243-81. Review.

PMID:
10803637
3.

Opioid and Cannabinoid System in Food Intake.

Pomorska DK, do-Rego JC, do-Rego JL, Zubrzycka M, Janecka A.

Curr Pharm Des. 2016;22(10):1361-70. Review.

PMID:
26806346
4.

Endocannabinoid system and alcohol addiction: pharmacological studies.

Colombo G, Serra S, Vacca G, Carai MA, Gessa GL.

Pharmacol Biochem Behav. 2005 Jun;81(2):369-80. Review.

PMID:
15939463
5.

[Cannabis and cannabinoids as drugs].

Khiabani HZ, Mørland J.

Tidsskr Nor Laegeforen. 2007 Mar 1;127(5):579-82. Review. Norwegian.

6.

Self-administration of cannabinoids by experimental animals and human marijuana smokers.

Justinova Z, Goldberg SR, Heishman SJ, Tanda G.

Pharmacol Biochem Behav. 2005 Jun;81(2):285-99. Review.

7.

Cannabinoid-opioid interactions during neuropathic pain and analgesia.

Bushlin I, Rozenfeld R, Devi LA.

Curr Opin Pharmacol. 2010 Feb;10(1):80-6. doi: 10.1016/j.coph.2009.09.009. Epub 2009 Oct 25. Review.

8.

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.

Tanda G, Goldberg SR.

Psychopharmacology (Berl). 2003 Sep;169(2):115-34. Epub 2003 Jun 24. Review.

PMID:
12827346
9.

Effects of opioids, cannabinoids, and vanilloids on body temperature.

Rawls SM, Benamar K.

Front Biosci (Schol Ed). 2011 Jun 1;3:822-45. Review.

10.

Evidence for novel cannabinoid receptors.

Begg M, Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Mo FM, Liu J, Kunos G.

Pharmacol Ther. 2005 May;106(2):133-45. Epub 2005 Jan 11. Review.

PMID:
15866316
11.

Drug addiction.

Justinova Z, Panlilio LV, Goldberg SR.

Curr Top Behav Neurosci. 2009;1:309-46. doi: 10.1007/978-3-540-88955-7_13. Review.

12.
13.

Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.

Maccioni P, Colombo G, Carai MA.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):55-9. Review.

PMID:
20201816
14.

The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence.

Colombo G, Orrù A, Lai P, Cabras C, Maccioni P, Rubio M, Gessa GL, Carai MA.

Mol Neurobiol. 2007 Aug;36(1):102-12. Epub 2007 Jul 3. Review.

PMID:
17952655
15.
16.

Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects.

Manzanares J, Ortiz S, Oliva JM, Pérez-Rial S, Palomo T.

Alcohol Alcohol. 2005 Jan-Feb;40(1):25-34. Epub 2004 Nov 18. Review.

PMID:
15550451
17.

β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.

Raehal KM, Bohn LM.

Handb Exp Pharmacol. 2014;219:427-43. doi: 10.1007/978-3-642-41199-1_22. Review.

18.
19.

Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.

Cooper ZD, Haney M.

Addict Biol. 2008 Jun;13(2):188-95. doi: 10.1111/j.1369-1600.2007.00095.x. Epub 2008 Feb 14. Review.

20.

Cannabinoid tolerance and dependence.

Lichtman AH, Martin BR.

Handb Exp Pharmacol. 2005;(168):691-717. Review.

PMID:
16596793

Supplemental Content

Support Center